Cargando…
Targeting the NLRP3 Inflammasome via BTK
The NLRP3 inflammasome represents a critical inflammatory machinery driving pathology in many acute (e. g., myocardial infarction or stroke) and chronic (Alzheimer's disease, atherosclerosis) human disorders linked to the activity of IL-1 cytokines. Although the therapeutic potential of NLRP3 i...
Autor principal: | Weber, Alexander N. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947255/ https://www.ncbi.nlm.nih.gov/pubmed/33718366 http://dx.doi.org/10.3389/fcell.2021.630479 |
Ejemplares similares
-
Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease
por: Woo, Samuel, et al.
Publicado: (2023) -
Exosomes Regulate NLRP3 Inflammasome in Diseases
por: Li, Zhangwang, et al.
Publicado: (2022) -
NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity
por: Wei, Shanshan, et al.
Publicado: (2021) -
Targeting Solid Tumors With BTK Inhibitors
por: Uckun, Fatih M., et al.
Publicado: (2021) -
Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction
por: Chevriaux, Angélique, et al.
Publicado: (2020)